Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Intracranial Aneurysms - Market Insights, Competitive Landscape and Market Forecast–2027
... Intracranial Aneurysms market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Intracranial Aneurysms market report provides an overview of Intracranial Aneurysms , applications of Intracranial Aneurysms as well as its advantages ... Read More
-
2022 Global Forecast for Clinical Trial Packaging Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Global Clinical Trial Imaging Market Size, Status and Forecast 2022-2028
... from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028. Fully considering the economic change by this health crisis, In-house Imaging Service accounting for 30.61% of the Clinical Trial Imaging global market ... Read More
-
eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Randomization and Trial Supply Management, Electronic Clinical Outcome Assessment, Electronic Trail Master Files, Others), By Delivery Mode (Web-hosted, On-premise, Cloud-based), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... On-premise, Cloud-based), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global eClinical ... Read More
-
Drug Resistant Epilepsy - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Coccidioidomycosis - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Coccidioidomycosis Understanding ... Read More
-
Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis, and Competitive Landscape - Analysis and Forecast, 2022-2032
... Industry Overview The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032. The growth in the ... Read More
-
Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 14,000 incident cases of WM across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of WM, and Beigene is a key player in the disease space. A ... Read More
-
Clinical Trials Sector Scorecard, Q2 2022 Update - Thematic Research
... 2022, Novo Nordisk initiated more trials with virtual components and also posted more jobs related to virtual care. Daiichi Sankyo and Takeda are planning a study in Japan that will look at the feasibility of ... Read More
-
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trials Review, 2022 provides an overview of Uterine Leiomyoma (Uterine Fibroids) Clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine Leiomyoma (Uterine Fibroids). Report includes an overview ... Read More
-
Panic Disorders Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Panic Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Panic Disorders. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Metastatic Melanoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Melanoma. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Hypothyroidism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... overview of Hypothyroidism Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypothyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across ... Read More
-
Down Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Down Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Down Syndrome. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027
... are formed in the tissues of the cervix, the lower part of the uterus that connects to the vagina. Human papillomavirus (HPV) infection is the major risk factor for cervical cancer. According to Arizton's estimates, ... Read More
-
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than one million diagnosed prevalent cases of IC across 16 pharmaceutical markets. There are four FDA approved branded marketed products available for the treatment of IC. The IC pipeline consists of over ... Read More
-
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 349,000 diagnosed prevalent cases of polymyositis (PM) and 165,000 diagnosed prevalence case of dermatomyositis (DM) across 16 pharmaceutical markets. There are 13 FDA approved drugs available for the treatment of PM/DM. ... Read More
-
Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 2022, there will be more than 169,000 diagnosed prevalent cases of FSGS across 16 pharmaceutical markets. There are several marketed genericized drugs for the treatment of FSGS, which are mostly immune-suppressing in nature. A total ... Read More
-
Global Healthcare Smart ContractsMarket Size study, byBlockchain Type (Hyperledger Fabric, MultiChain56, Ethereum, Others), by Application (Data Exchange & Interoperability, Clinical Trials, Supply Chain Management, Claims Adjudication & Billing Management, Others), by End-Use (Healthcare Provider, Healthcare Payer, Drug & Medical, Others) and Regional Forecasts 2022-2028
... Payer, Drug & Medical, Others) and Regional Forecasts 2022-2028 Global Healthcare Smart ContractsMarket is valued at approximately XX in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over ... Read More
-
Global Salivary Gland Cancer Treatment Market - 2022-2029
... growing at a CAGR of XX % during the forecast period (2022-2029). Salivary gland cancer is rare cancer that develops in the tissue of the salivary glands. These glands control the production of saliva. A ... Read More
-
Global Cancer Cachexia Market - 2022-2029
... weight loss, anorexia, asthenia, and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. The signs and symptoms of cachexia are considered the prognostic parameters in ... Read More
-
Global Tonsil Cancer Treatment Market - 2022-2029
... at a CAGR of XX% during the forecast period (2022-2029). Throat cancer is a form of neck and head cancer that affects the larynx, vocal cords, and other throat parts. Cough, change in voice, painful ... Read More
-
Global Pediatric Clinical Trials Market Size study, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Treatment Studies and Observational Studies), By Therapeutic Area (Respiratory Diseases, Infectious Diseases, Oncology, Diabetes and Other Therapeutic Areas), and Regional Forecasts 2022-2028
... and Other Therapeutic Areas), and Regional Forecasts 2022-2028 Global Pediatric Clinical Trials Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX ... Read More
-
Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... increase in the US, the UK, and Japan by 0.88% between 2021 and 2031. Treatment regimens for NTM are a combination therapy of at least three different antibiotics, frequently including macrolides. The greatest unmet needs ... Read More
Research Assistance
